Controllability in Cancer Metabolic Networks According to Drug Targets as Driver Nodes
Open Access
- 25 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11), e79397
- https://doi.org/10.1371/journal.pone.0079397
Abstract
Networks are employed to represent many nonlinear complex systems in the real world. The topological aspects and relationships between the structure and function of biological networks have been widely studied in the past few decades. However dynamic and control features of complex networks have not been widely researched, in comparison to topological network features. In this study, we explore the relationship between network controllability, topological parameters, and network medicine (metabolic drug targets). Considering the assumption that targets of approved anticancer metabolic drugs are driver nodes (which control cancer metabolic networks), we have applied topological analysis to genome-scale metabolic models of 15 normal and corresponding cancer cell types. The results show that besides primary network parameters, more complex network metrics such as motifs and clusters may also be appropriate for controlling the systems providing the controllability relationship between topological parameters and drug targets. Consequently, this study reveals the possibilities of following a set of driver nodes in network clusters instead of considering them individually according to their centralities. This outcome suggests considering distributed control systems instead of nodal control for cancer metabolic networks, leading to a new strategy in the field of network medicine.This publication has 63 references indexed in Scilit:
- Predicting selective drug targets in cancer through metabolic networksMolecular Systems Biology, 2011
- Predicting selective drug targets in cancer through metabolic networksMolecular Systems Biology, 2011
- Large-scale in silico modeling of metabolic interactions between cell types in the human brainNature Biotechnology, 2010
- Metabolic genes in cancer: Their roles in tumor progression and clinical implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructionsMolecular Systems Biology, 2010
- HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiologyMolecular Systems Biology, 2010
- Computational reconstruction of tissue‐specific metabolic models: application to human liver metabolismMolecular Systems Biology, 2010
- Predicting new molecular targets for known drugsNature, 2009
- Complex networks: Structure and dynamicsPhysics Reports, 2006
- Network motifs in the transcriptional regulation network of Escherichia coliNature Genetics, 2002